JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Skyward Specialty Announces Pricing of Upsized Initial Public Offering
-
Skyward Specialty Announces Pricing of Upsized Initial Public Offering
-
Skyward Specialty Announces Pricing of Upsized Initial Public Offering
-
Xpansiv Completes Acquisition of Evolution Markets, Closes Capital Raise with New Investors Bank of America, and Goldman Sachs
-
Redwood Trust (RWT) Prices 2.6M Preferred Share Offering
-
Redwood Trust Announces Pricing of Public Offering of Preferred Stock
-
Lumotive and AXIBO Partner to Bring Solid-state 3D Lidar Sensing to Photography and Cinematography Automation
-
Skyward Specialty Announces Launch of Initial Public Offering
-
Skyward Specialty Announces Launch of Initial Public Offering
-
Skyward Specialty Announces Launch of Initial Public Offering
-
Lumotive Adds New Investments from USAA and Uniquest to a Strategic Funding Round Led by Samsung Ventures
-
Terns Announces Closing of Public Offering of Shares of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Terns Announces Closing of Public Offering of Shares of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
JMP Securities Downgrades Applied Molecular Transport (AMTI) to Market Perform
-
Terns Pharmaceuticals (TERN) Prices 10.35M Share Offering at $7.25/sh
-
Terns Announces Pricing of $75 Million Public Offering
-
Terns Announces Pricing of $75 Million Public Offering
-
JMP Securities continue to like Palo Alto Networks (PANW)
-
Terns Pharmaceuticals Inc. (TERN) Launches $75M Public Offering
-
Terns Announces Proposed Public Offering
-
Terns Announces Proposed Public Offering
-
Prothena (PRTA) Prices 3.25M Share Offering at $56.50/sh
-
Prothena Announces Pricing of Public Offering of 3,250,000 Ordinary Shares
-
JMP Securities Downgrades Sabra Healthcare REIT Inc. (SBRA) to Market Perform
-
Adicet Bio (ACET) shares plunge following ADI-001 Phase 1 data
-
JMP Securities Downgrades Boyd Gaming (BYD) to Market Perform
-
JMP Securities Starts Full House Resorts (FLL) at Market Outperform
-
Vor Biopharma (VOR) Prices Underwritten Offering of Common Stock and Concurrent Private Placement for Aggregate Proceeds of $115.8 Million
-
Vor Bio Prices Underwritten Offering of Common Stock and Concurrent Private Placement for Aggregate Proceeds of $115.8 Million
-
iBio to Participate in the JMP Securities Hematology and Oncology Summit
-
BioCryst to Present at JMP Securities Hematology & Oncology Summit
-
Immutep to Participate in The JMP Securities Hematology and Oncology Summit
-
Terns Pharmaceuticals to Present at the 2022 JMP Securities Hematology and Oncology Summit
-
Protagonist Therapeutics to Participate in the JMP Securities Hematology and Oncology Summit
-
Deciphera Pharmaceuticals, Inc. to Present at the JMP Securities Hematology and Oncology Summit
-
Aura Biosciences (AURA) Prices 6.7M Shares at $12
-
Aura Biosciences Announces Pricing of Public Offering of Common Stock
-
Exelixis to Present at the Virtual JMP Securities Hematology and Oncology Summit on December 7, 2022
-
Aura Biosciences (AURA) to Offer Common Stock
-
Aura Biosciences Announces Proposed Public Offering of Common Stock
-
Adicet Bio to Present at the Virtual JMP Securities Hematology and Oncology Summit
-
SELLAS Life Sciences to Participate in the JMP Securities Hematology and Oncology Summit
-
Elevation Oncology to Participate at the JMP Securities Hematology and Oncology Summit
-
Iovance Biotherapeutics to Present at Upcoming Conferences
-
HOOKIPA to Participate in The JMP Securities Hematology and Oncology Summit
-
Iovance Biotherapeutics to Present at Upcoming Conferences
-
HOOKIPA to Participate in The JMP Securities Hematology and Oncology Summit
-
CTI BioPharma to Present at the JMP Securities Hematology and Oncology Summit
-
Taysha Gene Therapies to Participate in JMP Securities Hematology and Oncology Summit
-
Rallybio to Present at the JMP Securities Hematology and Oncology Summit

